GSK to Invest £400 Million in UK R&D Expansion
British pharmaceutical company GSK announced a £400 million investment over the next three years to strengthen its UK operations, including relocating its research and development activities to a new Cambridge facility. The move is...
Novo Nordisk Cuts Wegovy Prices with New Subscription Plan to Boost U.S. Access
Novo Nordisk has introduced a discounted subscription plan for its blockbuster obesity drug Wegovy in the United States, aiming to expand access for patients paying out of pocket and regain momentum against rival Eli...